Jobs / United States / Astrazeneca Pharmaceuticals Lp

Case Manager, Rare Endocrinology & Rare Tumor (RERT) Team (Pacific Time Zone)

Astrazeneca Pharmaceuticals Lp · 🇺🇸 US

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles2 certified filings for “Senior Manager, ENHERTU Marketing” (Marketing Managers) in MD: $180k–$180k, median $180k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Astrazeneca Pharmaceuticals Lp

99 H-1B filings certified since Oct 2025

The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →

About the role

Remote position supporting Pacific Standard Time Zone ( 11 :30am EST – 8 pm EST) with occasional patient meeting and HCP office support , up to 6 x/year, outside those hours of operation. Up to 1 5 % potential travel to existing Alexion sites and off-site meetings , patient and HCP engagements by request and when appropriate . Start date as soon as possible.     This is what you will do:   This position is a high-touch Patient Services role centered on delivering personalized support to patients within the Alexion Rare Disease patient journey.     The Case Manager (CM) serves as the primary point of contact to patients and caregivers throughout their treatment journey from onboarding, interim treatment coordination, and lon g- term customized treatment adherence support.  CMs provide disease state education, treatment support, and access for patients with rare and ultra-rare diseases.  CMs ensure patient treatment compliance and provide resolutions to treatment issues for patients through communication and collaboration with both internal and external stakeholder partners.     You will be responsible for :   Patient Support & Navigation (70%)   • Patient’s Initial and Long-term Support: Provide initial and ongoing patient interactions to address questions and integrate therapy into their daily lives   • Act as the primary point of contact for case management and onboarding activities specific to the patient   • Place Welcome Calls: After case creation in the CRM, place the required welcome calls to patient (and HCP in coordination with SP vendor) and introduce the program or confirm required support respectively   • Share Disease, Product & Program Education Materials: Share materials on disease, diagnosis, and treatment support with patients   • Introduce Patient Community: During the first touchpoint, Connect the patient to the ALXN patient community and inform them about available advocacy groups for the indication   • Communicate Benefits Investigation Results: On receiving the BI results from the SP vendor, contact the patient and share results   • Coordinate Injection Training Support: Assist patients in receiving In-home or virtual injection training assistance during first injection and coordinate follow up service as needed for second round of injection training (also offer infusion support)   • Conduct Adherence Program Touchpoints: Trigger initiation of adherence program on conclusion of onboarding and connect with patients through defined channels for the determined touchpoints based on product specific programs   • Execute Mentorship Program: Engage appropriate patients to become mentors if desired to new patients starting therapy and enable them to connect   • Support Patients who Restart on Treatment: Reconnect with patients who have lapsed and decided to restart on treatment, offer support services   • Conduct Annual BI Communications with patients   • Practice vigilant documentation and record keeping during all patient interactions as to maintain high visibility into patient case status and ease resolution processes, when needed   • Properly and immediately report Adverse Events during any customer interactions in the PV Event Reporting Tool       Internal Cross-Functional Collaboration (15%)   • Develop compliant and collaborative professional relationships with all relevant internal and external customers including but not limited to Field Reimbursement Managers, Regional Account Managers, Customer Operations Representatives, medical accounts, Funding Specialists, Access Specialists, Specialty Pharmacies, site of care staff, and office coordinators.   • Effectively escalate access issues by informing the right stakeholders of actions to be taken to resolve any pending items in a timely m

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-01 Last confirmed: 2026-10-02 How our data works → Report this job

Similar opportunities